Cue Biopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. 

CEO
Daniel R. Passeri
CEODaniel R. Passeri
Employees
57
Employees57
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
57
Employees57

CUE Key Statistics

Market cap
82.79M
Market cap82.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
132.13K
Average volume132.13K
High today
$2.51
High today$2.51
Low today
$2.34
Low today$2.34
Open price
$2.36
Open price$2.36
Volume
25.30K
Volume25.30K
52 Week high
$18.42
52 Week high$18.42
52 Week low
$2.30
52 Week low$2.30

CUE News

Simply Wall St 4d
Despite Lacking Profits Cue Biopharma Seems To Be On Top Of Its Debt - Simply Wall St

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a...

Despite Lacking Profits Cue Biopharma Seems To Be On Top Of Its Debt - Simply Wall St

CUE Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.